The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype
Open accessAbstract
OBJECTIVE: Specific autoantibodies characterize type 1 diabetes in childhood but are also found in adult-onset diabetes, even when initially non–insulin requiring, e.g., with latent autoimmune diabetes (LADA). We aimed to characterize adult-onset autoimmune diabetes. RESEARCH DESIGN AND METHODS: We consecutively studied 6,156 European diabetic patients attending clinics within 5 years of diagnosis (age range, 30–70 years) examined cross-sectionally clinically and for GAD antibodies (GADA) and antibodies to insulinoma-associated antigen-2 (IA-2A) and zinc-transporter 8 (ZnT8A). RESULTS: Of 6,156 patients, 541 (8.8%) had GADA and only 57 (0.9%) IA-2A or ZnT8A alone. More autoantibody-positive than autoantibody-negative patients were younger, leaner, on insulin (49.5 vs. 13.2%), and female (P < 0.0001 for each), though LADA patients (9.7% of total) did not show categorically distinct clinical features from autoantibody-negative type 2 diabetes. Similarly, more GADA patients with high (>200 World Health Organization IU) (n = 403) compared with low (n = 138) titer were female, lean, and insulin treated (54.6 vs. 39.7%) (P < 0.02 for each). Autoantibody-positive patients usually had GADA (541 of 598; 90.5%) and had LADA more often than type 1 autoimmune diabetes (odds ratio 3.3). CONCLUSIONS: Adult-onset autoimmune diabetes emerges as a prevalent form of autoimmune diabetes. Our results indicate that adult-onset autoimmune diabetes in Europe encompasses type 1 diabetes and LADA in the same broad clinical and autoantibody-positive spectrum. At diagnosis, patients with adult-onset autoimmune diabetes are usually non–insulin requiring and clinically indistinguishable from patients with type 2 diabetes, though they tend to be younger and leaner. Only with screening for autoantibodies, especially GADA, can they be identified with certainty.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“LADA is the most common form of autoimmune diabetes mellitus diagnosed in adults, with a prevalence in Europe, China and the United Arab Emirates between 3 and 12 times higher than that of adult-onset T1DM77–79.”
From The epidemiology of type 1 diabetes mellitus in older adults (2025) · cites this paper as [77]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Genetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705894104 · Cited by 1,014
Turner, R., Stratton, I., Horton, V., Manley, S., Zimmet, P., Mackay, I. R., Shattock, M., Bottazzo, G. F., & Holman, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03062-6 · Cited by 779
Gale, E. A. M., & Gillespie, K. M. (2001) · Diabetologia · doi:10.1007/s001250051573 · Cited by 558
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
Tuomi, T., Carlsson, A., Li, H., Isomaa, B., Miettinen, A., Nilsson, A.-L., Nissén, M., Ehrnström, B. O., Forsén, B., Snickars, B., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.1.150 · Cited by 504
Latent autoimmune diabetes in adults (LADA) should be less latent
Fourlanos, S., Dotta, F., Greenbaum, C. J., Palmer, J. P., Rolandsson, O., Colman, P. G., & Harrison, L. C. (2005) · Diabetologia · doi:10.1007/s00125-005-1960-7 · Cited by 411
Diabetes Antibody Standardization Program: first assay proficiency evaluation
Bingley, P. J., Bonifacio, E., Mueller, P. W., & Laboratories, P. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1128 · Cited by 362
Latent Autoimmune Diabetes in Adults
Naik, R. G., Brooks-Worrell, B. M., & Palmer, J. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1120 · Cited by 249
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 339
Herranz-Antolín, S., Cotón-Batres, C., López-Virgos, M. C., Esteban-Monge, V., de Frutos, V. Á., & Torralba, M. (2024) · Endocrine · doi:10.1007/s12020-024-03901-5 · Cited by 4
Xenou, M., Zoupas, I., LYGNOS, D., & Fousteris, E. (2022) · Journal of Medical Case Reports · doi:10.1186/s13256-022-03523-3 · Cited by 4
Rončáková, M., Davani, A., Mikušová, V., Ságová, I., Novodvorský, P., & Martinka, E. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01440-2 · Cited by 5
Wu, P., Song, Y., Chen, Z., Xia, J., & Zhou, Y. (2023) · Endocrine · doi:10.1007/s12020-023-03539-9 · Cited by 5
Hoffman, W. H., Artlett, C. M., Boodhoo, D., Gilliland, M. G. F., Ortiz, L., Mulder, D., Tjan, D. H. T., Martin, A., Tatomir, A., & Rus, H. (2017) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2017.05.013 · Cited by 4
Teasing Diabetes Apart, One Locus at a Time
Leslie, R. D., & Grant, S. F. A. (2018) · Diabetes Care · doi:10.2337/dci17-0046 · Cited by 4
Self-citationEbe, K., Bando, H., Muneta, T., Bando, M., & Yonei, Y. (2019) · Institutional Repositories DataBase (IRDB) · Cited by 4
Effects of rosuvastatin on serum glucose and insulin in hyperuricemic rats
Xilifu, D., Tuerxun, Z., Nuermaimaiti, B., Aili, A., Rehemu, N., Sun, H., & Zhang, X. (2022) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-022-00595-1 · Cited by 4
Welters, A., Tittel, S. R., Reinehr, T., Weghuber, D., Wiegand, S., Karges, W., Freiberg, C., Meißner, T., Schloot, N. C., & Holl, R. W. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13450 · Cited by 4
Self-citationLatent Autoimmune Diabetes in an Adult Male Presenting With Diabetic Ketoacidosis (DKA)
Imam, S. K., Hassan, F. M., & Mohamed, H. (2023) · Cureus · doi:10.7759/cureus.33847 · Cited by 4
The Dynamic Origins of Type 1 Diabetes
Leslie, R. D., & Grant, S. F. A. (2018) · Diabetes Care · doi:10.2337/dci18-0034 · Cited by 4
Self-citationO’Callaghan, S. (2016) · Physician Assistant Clinics · doi:10.1016/j.cpha.2016.08.003 · Cited by 6
Li, J., Lin, S., Deng, C., & Xu, T. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s298068 · Cited by 6
D’Addio, F., Nasr, M. B., Lunati, M. E., & Fiorina, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00075-8 · Cited by 3
Diagnosing and Managing LADA: A Review of the Overlooked Diabetes Subtype
Wojszczyk, M., Kulbacka, J., Dziedzic, K., Arczewski, F., Wójcikiewicz, M., Chuncia-Ileczko, M., Kacperczyk, J., Czyż, W., Pasek, P., & Ryniecka, J. (2025) · Quality in Sport · doi:10.12775/qs.2025.37.57142 · Cited by 3
Lomeli, L. D., Lundholm, M. D., Xiao, H., Zhou, K., & Pantalone, K. M. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.05.748 · Cited by 6
Islet autoantibody positivity in an adult population with recently diagnosed diabetes in Uganda
Kibirige, D., Sekitoleko, I., Balungi, P., Kyosiimire–Lugemwa, J., Lumu, W., Jones, A. G., Hattersley, A. T., Smeeth, L. L., & Nyirenda, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268783 · Cited by 3
Zhang, L., Tian, Q., Guo, K., Wu, J., Ye, J., Ding, Z., Zhou, Q., Huang, G., Li, X., Zhou, Z., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.948157 · Cited by 4
Fan, W., Nan, X., Peng, Y., Li, X., Xiang, Y., Yan, X., Xie, Z., Zhou, H., Tang, X., Cheng, J., et al. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3592 · Cited by 2
Modern understanding of latent autoimmune diabetes in adults
Иванович, Г. И., Rusyaeva, N. V., Nikonova, T. V., Кононенко, И. В., & Shestakova, M. V. (2023) · Diabetes Mellitus · doi:10.14341/dm12994 · Cited by 4
Olamoyegun, M. A., Ala, O. A., & Ugwu, E. T. (2020) · Pan African Medical Journal · doi:10.11604/pamj.2020.37.35.25191 · Cited by 3
Diabetes mellitus – um «continuum» fisiopatológico
Guelho, D., Paiva, I., & Carvalheiro, M. C. (2013) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.1016/j.rpedm.2013.05.002 · Cited by 5
Yousefzadeh, G., Gozashti, M. H., Najafipour, H., Gholamhosseinian, N. A., Bahramnejad, A., & Shokouhi, M. (2015) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2015.09.013 · Cited by 3
C-peptide persistence in type 1 diabetes: ‘not drowning, but waving’?
Leslie, R. D., & Vartak, T. (2019) · BMC Medicine · doi:10.1186/s12916-019-1415-5 · Cited by 3
Self-citationEditorial: Latent Autoimmune Diabetes in Adults (LADA)
Leslie, R. D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1002776 · Cited by 3
Self-citationEl-Malky, A. M., Naik, R. G., & Elnouman, A. A. (2020) · Clinical Diabetology · doi:10.5603/dk.2020.0007 · Cited by 2
Latent Autoimmune Diabetes in Adults: Diagnostic and Therapeutic Challenges
Joseph, J. (2025) · Cureus · doi:10.7759/cureus.92356 · Cited by 2
Current Clinical Features of Diabetic Ketoacidosis in Adults: A German Multicenter Study 2022–2023
Linck, J. A., Michels, C., Schwanstecher, A., Schamarek, I., Hinsch, D., Terkamp, C., Ringel, C., Hoyer, A., Holstein, D. J. F., Altmeier, M., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251380863 · Cited by 2
Saiprasad, S., & Swamy, N. (2026) · Cureus · doi:10.7759/cureus.102964 · Cited by 2
Non obesity, autoimmunity and the missing pieces of diabetes in the adult
Seshadri, K. (2013) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-013-0122-6 · Cited by 2
Kp, Z., & Попова, В. В. (2016) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.7.79.2016.86414 · Cited by 2
Ding, B., Li, F.-F., Zhai, X., Ye, L., Hu, Y., & Ma, J. (2020) · BioMed Research International · doi:10.1155/2020/6259437 · Cited by 2
Sangma, H. S., Singh, A. K., Srivastava, A., & Misra, V. (2022) · Annals of the National Academy of Medical Sciences (India) · doi:10.1055/s-0041-1741063 · Cited by 2
Miao, Y., Wang, J., Zhang, B., Zhang, W., Xu, X., Hou, Y., Ding, Q., Yu, C., Zhang, Z., Bi, Y., et al. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3587 · Cited by 2
Jia, X., Wenzlau, J. M., Zhang, C., Dong, F., Waugh, K., Leslie, R. D. G., Rewers, M. J., Michels, A. W., & Yu, L. (2025) · Diabetes · doi:10.2337/db24-0571 · Cited by 3
Self-citationLatent Autoimmune Diabetes in Adults: A Diagnostic Challenge in Elderly Patients
Monteiro, F., Artilheiro, C., Shara, T., Andrade, M. T., dos Santos, L. S., Nunes, A., Ramalho, S., & Escarigo, C. (2025) · Cureus · doi:10.7759/cureus.84457 · Cited by 2
Stratifying Diabetes: Desperately Seeking Specificity
Leslie, R. D., & Jerram, S. T. (2017) · Diabetes · doi:10.2337/dbi16-0074 · Cited by 2
Self-citationZielgerichtete Erstdiagnostik bei Typ-1-Diabetes
Kalscheuer, H., & Lehnert, H. (2017) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0042-114798 · Cited by 2
Kumar, A. (2017) · Journal of Endocrinology and Diabetes · doi:10.15226/2374-6890/4/3/00180 · Cited by 1
Особливості перебігу діабетичної хвороби нирок у хворих на латентний автоімунний діабет дорослих
Tsaryk, I., & Pashkovska, N. V. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.17.2.2021.230565 · Cited by 3
Wang, Z., Guo, L., Chen, S., Guan, J., Powell, M. J., Furmaniak, J., Smith, B. R., & Chen, L. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01778-8 · Cited by 2
Zampetti, S., & Buzzetti, R. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_9 · Cited by 2
Self-citationKhoshroo, M. (2016) · International Journal of Pure & Applied Bioscience · doi:10.18782/2320-7051.2387 · Cited by 2
Autoimmunity in latent autoimmune diabetes in adults
Delitala, A., & U.O.C di Medicina Generale 2, A. O.-U. D. S. (2019) · AIMS Medical Science · doi:10.3934/medsci.2019.2.132 · Cited by 2
Diabetes Mellitus: A Group of Genetic-Based Metabolic Diseases
Sanhueza, L., Durruty, P., Vargas, C., Vignolo, P., & Elgueta, K. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89924 · Cited by 3
Wod, M., Yderstræde, K. B., Halekoh, U., Beck-Nielsen, H., & Højlund, K. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.09.014 · Cited by 1
Lada or Type 2 Diabetes Mellitus - A Challenging Diagnosis in Clinical Approach
Custură, L. M., Deteșan, O., Tilinca, R. M., Schmiedt, R. A., Bacso, B. I., & Tilinca, M. C. (2021) · Acta Medica Transilvanica · doi:10.2478/amtsb-2021-0052 · Cited by 1
Edstorp, J., Rossides, M., Ahlqvist, E., Alfredsson, L. S., Askling, J., Giuseppe, D. D., Grill, V., Sørgjerd, E. P., Tuomi, T., Åsvold, B. O., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06302-5 · Cited by 1
Lampousi, A., Ahlqvist, E., Alfredsson, L. S., Edstorp, J., Giuseppe, D. D., Grill, V., Löfvenborg, J. E., Padyukov, L., Tuomilehto, J., Åsvold, B. O., et al. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.09.021 · Cited by 1
Self-citationNiveatha, S., Raju, A., Revathy, G., & Pugulendi, S. (2025) · Journal of Diabetology · doi:10.4103/jod.jod_46_25 · Cited by 1
Reddy, V. Y. M., Maramreddy, V. S. R., & Ramireddy, R. J. (2026) · Cureus · doi:10.7759/cureus.105361 · Cited by 1
Keysendal, E., Carlsson, S., Lampousi, A., Hampe, C. S., Huerta, J. M., Kerrison, N. D., Nilsson, P. M., Pala, V. M., Schulze, M. B., Sharp, S. J., et al. (2026) · Metabologia · doi:10.1007/s44357-026-00003-9 · Cited by 1
Characteristic Traits of Type 1 Diabetes by Age at Presentation Go Over the Rainbow
Leslie, R. D., Zhou, Z., & Pozzilli, P. (2026) · Diabetes Care · doi:10.2337/dci26-0049 · Cited by 1
Self-citationGlutamic Acid Decarboxylase Autoantibodies Role in Reclassifying Diabetes of Adulthood in Basrah
Mansour, A. (2015) · International Journal of Clinical Endocrinology and Metabolism · doi:10.17352/ijcem.000004 · Cited by 1
Suárez, C. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000275 · Cited by 1
Latent Autoimmune Diabetes in Adults
Torres, J. E. E. (2018) · InTech eBooks · doi:10.5772/intechopen.72685 · Cited by 1
Zielgerichtete Erstdiagnostik bei Typ-1-Diabetes
Kalscheuer, H., & Lehnert, H. (2018) · Diabetes aktuell · doi:10.1055/a-0621-8419 · Cited by 1
Typ-1-Diabetes, LADA oder „Doppeldiabetes“?
Hummel, M., & Füchtenbusch, M. (2017) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-017-9579-4 · Cited by 1
Grenzformen zwischen Typ-1- und Typ-2-Diabetes
Hummel, M. (2020) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-020-0577-6 · Cited by 1
Prevalence of risk factors of cardiometabolic complications in latent autoimmune diabetes in adults
Tsaryk, I., Pashkovska, N. V., & Ilashchuk, O. (2021) · Bukovinian Medical Herald · doi:10.24061/2413-0737.xxv.2.98.2021.20 · Cited by 2
Byndoor, Y., & Sagar, T. V. (2023) · Current Trends in Pharmacy and Pharmaceutical Chemistry · doi:10.18231/j.ctppc.2023.004 · Cited by 1
Fu, X., Tan, Q., Wei, W., Ding, S., & Wang, Z. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01435-x · Cited by 1
Latent Autoimmune Diabetes in Adults (LADA) Occurring in a Patient with Primary Biliary Cholangitis
Lee, B., Pak, K., & Pockros, P. J. (2024) · The American Journal of Medicine · doi:10.1016/j.amjmed.2024.09.012 · Cited by 1
Nolasco-Rosales, G. A., Martínez‐Magaña, J. J., Juárez-Rojop, I. E., Rodríguez-Sánchez, E., Ruíz-Ramos, D., Velázquez, J. A. V., Bustos-Gamiño, M. N., Medina‐Mora, M. E., Tovilla‐Zárate, C. A., Cruz-Castillo, J. D., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810154 · Cited by 1
Mitsui, E., Satomura, A., Oikawa, Y., Haisa, A., & Shimada, A. (2024) · Diabetology International · doi:10.1007/s13340-024-00776-9 · Cited by 1
Is Type 2 Diabetes an Autoimmune Disorder of Gradual Onset?
Kotsa, K. (2014) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2014.01.00018 · Cited by 1
Latenter Autoimmundiabetes im Erwachsenen- und Kindesalter
Welters, A., & Schloot, N. C. (2019) · Der Diabetologe · doi:10.1007/s11428-019-00556-z · Cited by 1
Self-citationAlcohol, tobacco and the risk of LADA-latent autoimmune diabetes in adults
Rasouli, B. S. (2016) · Figshare · Cited by 1
Ionescu-Tirgoviste, C. (2018) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2018.520 · Cited by 2
Neues zum „late autoimmune diabetes of the adult“ in Europa
Itariu, B. K., & Stulnig, T. M. (2013) · Der Diabetologe · doi:10.1007/s11428-013-1075-6
Late‐onset type 1 diabetes in P āsifika migrants living in A uckland
Purea, T., McCready, F., Dunn, P. P. J., & Cundy, T. (2014) · Internal Medicine Journal · doi:10.1111/imj.12326
Positive conversion of GAD autoantibody in patients with presumed type 2 diabetes
Kubo, F., Takahara, M., Yasuda, T., Katakami, N., Matsuoka, T., & Shimomura, I. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0657-0
Clinical Heterogeneity of Diabetes in Young Korean Patients
Park, Y. (2014) · Journal of Korean Diabetes · doi:10.4093/jkd.2014.15.4.190
From THE INSTITUTE OF ENVIRONMENTAL MEDICINE
Giuseppe, D. D. (2014)
LADA-Patienten nur mit Autoantikörper-Screening identifizierbar
Schloot, N. C. (2013) · Info Diabetologie · doi:10.1007/s15034-013-0257-z
Self-citationCellular Immunological Mechanisms Contributing to Diabetes Pathogenesis
Radenkovic, M. (2016) · Lund University Publications (Lund University)
Mischformen und Überlappung des Typ-1- und des Typ-2-Diabetes
Füchtenbusch, M. (2017) · Der Diabetologe · doi:10.1007/s11428-017-0214-x
Antigen Deimination in Human Type 1 Diabetes and Nonobese Diabetic Mice
Nguyen, H. Q. T., & James, E. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-58244-3_10
Maskierter Typ-1-Diabetes oder doch Typ-2-Diabetes?
Schloot, N. C. (2018) · Info Diabetologie · doi:10.1007/s15034-018-1260-1
Self-citationMcGovern, A. P. (2018) · Surrey Research Insight Open Access (The University of Surrey)
Zielgerichtete Erstdiagnostik bei Typ-1-Diabetes
Kalscheuer, H., & Lehnert, H. (2018) · Diabetologie und Stoffwechsel · doi:10.1055/s-0044-102039
Löfvenborg, J. E. (2019) · Figshare
LADA – Latenter Autoimmuner Diabetes im Erwachsenenalter
Hummel, M., & Füchtenbusch, M. (2019) · Diabetes aktuell · doi:10.1055/a-0957-5528
Immune pathogenesis, immune intervention & prediction in Type 1 diabetes
Schloot, N. C. (2015) · doi:10.4155/fseb2013.14.39
Self-citationHvordan behandle LADA-diabetes?
Grill, V., & Hals, I. K. (2019) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.19.0579
Recent Research Findings for Slowly-Progressive Insulin-Dependent Diabetes Mellitus (SPIDDM)
Bando, H. (2019) · Institutional Repositories DataBase (IRDB)
Current view of diagnosis and treatment of latent autoimmune diabetes in adults
Urbanová, J., Brunerová, L., Malinovská, J., Pelechová, B., Koberová, L., & Brož, J. (2021) · Vnitřní lékařství · doi:10.36290/vnl.2021.021
Latent Autoimmune Diabetes in Adults: The Current Understanding and Challenge
Tseng, K.-B. (2021) · 內科學誌 · doi:10.6314/jimt.202104_32(2).02
Diabetes mellitus Typ 1 und autoimmunpolyglanduläres Syndrom (APS)
Badenhoop, K. W. J., & Schloot, N. C. (2022) · Der Diabetologe · doi:10.1007/s11428-021-00846-5
Self-citationTwo Fifth-Generation Fighter Pilots Discovered with Latent Autoimmune Diabetes
Zhang, J. X., Berry, J., Kim, N. M., Gray, J. J., Fotheringham, S., & Sauerwein, T. J. (2022) · Aerospace Medicine and Human Performance · doi:10.3357/amhp.5901.2022
Classification, diagnosis and presentation
FRCP, D. L. M. (2017) · Wiley eBooks · doi:10.1002/9781119052210.ch1
Latent autoimmune diabetes in adults: are we paying sufficient attention?
Hernández, M., & Mauricio, D. (2015) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2014.12.003
Self-citationZampetti, S., & Buzzetti, R. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_9-1
Self-citationExocrine Proteins Including Trypsin(ogen) as a Key Biomarker in Type 1 DiabetesPreprint
Bakinowska, L., Vartak, T., Phuthego, T., Taylor, M. R., Chandler, K. A., Jerram, S. T., The BOX Study Group, Williams, S., Feldmann, M., Johnston, D. G., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4106538
Self-citationAssociation of Autoimmune Thyroiditis with Latent Autoimmune Diabetes of Adults (LADA)
Sangma, H. S., Singh, A. K., Srivastava, A., Singh, R. S., & Misra, V. (2022) · Journal of Diabetology · doi:10.4103/jod.jod_121_21
Naroei, R., Mehranpoor, M., Mohammadi, M., & Lagzian, M. (2022) · International journal of basic science in medicine · doi:10.34172/ijbsm.2022.08 · Cited by 1
Metadata
- Authors
- Hawa, M. I., Kolb, H., Schloot, N., Beyan, H., Paschou, S. A., Buzzetti, R., Mauricio, D., De Leiva, A., Yderstraede, K., Beck-Neilsen, H., Tuomilehto, J., Sarti, C., Thivolet, C., Hadden, D., Hunter, S., Schernthaner, G., Scherbaum, W. A., Williams, R., Brophy, S., Pozzilli, P., Leslie, R. D., & on behalf of the Action LADA consortium
- Affiliations
- Queen Mary University of London (GB)
- Heinrich Heine University Düsseldorf (DE)
- Blizard Institute, Queen Mary University of London, London, U.K.
- Sapienza University of Rome (IT)
- Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)
- Hospital de Sant Pau (ES)
- Odense University Hospital, Odense, Denmark
- Odense University Hospital (DK)
- Finnish Institute for Health and Welfare (FI)
- Hôpital Edouard Herriot (FR)
- Royal Victoria Hospital (GB)
- Krankenanstalt Rudolfstiftung der Stadt Wien (AT)
- Swansea University (GB)
- Università Campus Bio-Medico (IT)
- Corresponding author
- Leslie, Richard David
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-03-14
- Volume
- 36
- Issue
- 4
- Pages
- 908-913
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3609504
- OpenAlex
- W1969080742
- Cited by
- 339
- References
- 24
- Citations by year
- 2026: 25 · 2025: 22 · 2024: 19 · 2023: 15 · 2022: 33 · 2021: 22 · 2020: 23 · 2019: 29 · 2018: 31 · 2017: 30 · 2016: 23 · 2015: 25 · 2014: 25 · 2013: 16
- FWCI
- 12.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- latent autoimmune diabetes in adults, type 1 diabetes, glutamic acid decarboxylase antibodies, IA-2 autoantibodies, autoantibody detection, clinical phenotype, type 2 diabetes misdiagnosis, insulin requirement, antibody titers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
